search
Back to results

Multiparametric Telemonitoring In Elderly People With Chronic Heart Failure

Primary Purpose

Heart Failure

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Telemonitoring
Standard care
Sponsored by
Campus Bio-Medico University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Heart Failure

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with heart failure

Exclusion Criteria:

  • Cognitive impairment precluding the use of the experimental device

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Telemonitoring + Standard care

    Standard care

    Arm Description

    Outcomes

    Primary Outcome Measures

    Hospital admissions or death
    Rate of hospital admissions for any reason or death

    Secondary Outcome Measures

    Acute heart failure events
    Rate of acute heart failure, defined as a worsening of the patient's condition that necessitates a change in regular medications

    Full Information

    First Posted
    July 25, 2013
    Last Updated
    July 31, 2013
    Sponsor
    Campus Bio-Medico University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01914588
    Brief Title
    Multiparametric Telemonitoring In Elderly People With Chronic Heart Failure
    Official Title
    Effectiveness of a Multiparametric Telemonitoring System on Prevention of Hospital Admissions and Mortality In Elderly People With Chronic Heart Failure
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2013
    Overall Recruitment Status
    Completed
    Study Start Date
    June 2012 (undefined)
    Primary Completion Date
    February 2013 (Actual)
    Study Completion Date
    July 2013 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Campus Bio-Medico University

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Heart failure is a chronic disease associated with an increasing risk of morbidity, disability, repeated hospitalizations and mortality. Telemedicine could promptly identify signs of worsening cardiac disease in order to improve elderly patients' home care and quality of life by reducing the need of hospital admissions and sanitary costs. The investigators present a randomized, parallel-group trial to test the ability of a multiparametric remote monitoring system, in addition to standard care, to promptly identify worsening of heart failure and prevent hospital admission and mortality.
    Detailed Description
    The participants were recruited in two settings: Patients discharged with a first diagnosis of heart failure from the Geriatric Acute Care ward of a teaching hospital ("Policlinico Campus Bio-Medico", Rome, Italy); Patients with a principal diagnosis of heart failure attending the outpatients clinic of the same hospital. All the participants were evaluated at baseline and at the end of the study using a multi-dimensional assessment including well validated and routinely used tools to screen geriatric patients in order to detect global, physical and instrumental autonomy and consequent degree of dependence, as well as cognitive status. The assessment tool included: Activities of daily living scale (ADL) and Instrumental activities of daily living scale (IADL); Abbreviated mental Test; Geriatric Depression Scale; Physical Activity Scale for the Elderly; Six-minute walking test; The Short Form Health Survey (SF-12); Cumulative Illness Rating Scale (CIRS); complete list of drugs. Once written consent form was obtained, participants were allocated to the study groups in a 1:1 ratio using a computer-generated random list of number. Participants were followed up for six months. Patients in the intervention group were monitored via a system called PHEBO (Platform for High tech Evaluation of Biometrics Observation) that consisted of a commercial Android-based smartphone and a kit of measurement instruments (sphygmomanometer, pulse oximeter and an electronic scale) with a bluetooth transmitter. The smartphone received via bluetooth the readings from the measurement instruments, communicated in real-time the readings to the central component of the system and issued reminders for the patient when measurement was scheduled. Patients in the telemonitoring group received a training session during which they were instructed on how to use the monitoring system and how to perform measurements in case of symptoms. At the end of the session correct comprehension of the system functioning was tested for each patient. A study physician was available on call during office hours to assist patients needing further instructions. A technician was also available in order to solve ingoing hardware malfunctioning. Participants unable to properly use the kit were excluded from the study. The kit was able to record peripheral oxygen saturation, heart rate, systolic, diastolic and average blood pressure, body weight, average physical activity. We set a specific schedule of the measurements: Blood pressure and heart rate: three times a day Peripheral oxygen saturation: three times a day Body weight: once a day Physical activity: recorded continuously. The data received were evaluated every day by a geriatrician. The monitor system displayed an alert when a measurement was outside a predetermined range. In case of abnormal readings, the physician contacted the patient to verify whether their symptoms had worsened or new symptoms had arose. In this event, the patient's adherence to therapy was checked and, if unsatisfactory, individually tailored interventions promoting adherence were carried up. Otherwise, an once appointment (for patients with milder abnormalities or symptoms) or a hospital admission was scheduled. Participants not included in the intervention group received standard care. In particular, patients discharged from the acute care ward received detailed instruction about medical therapy and lifestyle counselling. A follow-up visit was scheduled at 1 month after the discharge. A geriatrician was available for telephonic support from Monday to Friday, two hours/day. Patients enrolled in the ambulatory setting were followed by planned visits and by their general practitioner.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Heart Failure

    7. Study Design

    Primary Purpose
    Health Services Research
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    100 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Telemonitoring + Standard care
    Arm Type
    Experimental
    Arm Title
    Standard care
    Arm Type
    Active Comparator
    Intervention Type
    Procedure
    Intervention Name(s)
    Telemonitoring
    Intervention Description
    Use of wearable sensors able to record peripheral oxygen saturation, heart rate, systolic, diastolic and average blood pressure, body weight, average physical activity, with automatic transmission to the monitoring central.
    Intervention Type
    Other
    Intervention Name(s)
    Standard care
    Intervention Description
    Detailed instruction about medical therapy and lifestyle counseling Telephonic support by a geriatrician, available from Monday to Friday, two hours/day Follow-up visits
    Primary Outcome Measure Information:
    Title
    Hospital admissions or death
    Description
    Rate of hospital admissions for any reason or death
    Time Frame
    Six months
    Secondary Outcome Measure Information:
    Title
    Acute heart failure events
    Description
    Rate of acute heart failure, defined as a worsening of the patient's condition that necessitates a change in regular medications
    Time Frame
    Six months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with heart failure Exclusion Criteria: Cognitive impairment precluding the use of the experimental device
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Raffaele Antonelli Incalzi, MD
    Organizational Affiliation
    Campus Bio-Medico University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Multiparametric Telemonitoring In Elderly People With Chronic Heart Failure

    We'll reach out to this number within 24 hrs